Accumulating evidence from experimental and clinical studies suggests that GDM is essentially a state of chronic insulin resistance, largely mediated by proinflammatory cytokines that impair insulin signaling and reduce insulin secretion from pancreatic β-cells (3, 4). Here, INS is linked to Insulin resistance.